-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $708

Benzinga·10/08/2026 14:58:08
Listen to the news
RBC Capital analyst Lisa Walter maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target from $677 to $708.